|
28 Apr 2007 |
Ark Therapeutics Grp - Regulatory Update
|
|
27 Apr 2007 |
Sangamo BioSciences Initiates Additional Phase 2 Clinical Trial of Novel Therapy for Moderate to Severe Diabetic Neuropathy
|
|
25 Apr 2007 |
Ark Therapeutics Grp - Research Update
|
|
19 Apr 2007 |
Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
|
|
18 Apr 2007 |
Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference
|
|
18 Apr 2007 |
Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
|
|
18 Apr 2007 |
Introgen's Intravenous Nanoparticle Gene Therapy Shows Activity in Stage IV Lung Cancer Patients
|
|
18 Apr 2007 |
ProNAi Announces Preclinical Success for PNT2258 Therapeutic – Curative Events in Xenograft Mice for Difficult-to-Treat Non-Hodgkin's Lymphoma
|
|
17 Apr 2007 |
Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
|
|
17 Apr 2007 |
Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinson's Patients
|
|
17 Apr 2007 |
Regulatory Review Allows LCT Diabetes Clinical Program to Proceed
|
|
17 Apr 2007 |
Bioniche Presents Additional Data on the Anticancer Activity of MCC Against Peritoneal Carcinomatosis
|
|
14 Apr 2007 |
Ceregene Enrolling Patients For Phase 2 Clinical Trial Of Parkinson's Disease
|
|
12 Apr 2007 |
Oncolytics Biotech Inc. Proceeds to Initiate U.S. Phase II Sarcoma Clinical Trial
|
|
12 Apr 2007 |
Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals
|
|
05 Apr 2007 |
Genta Appeals FDA Decision on Genasense in CLL
|
|
31 Mar 2007 |
LCT reports major step forward for islet transplantation in diabetes patient
|
|
27 Mar 2007 |
Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC
|
|
26 Mar 2007 |
Osiris Therapeutics Announces Positive Results in Groundbreaking Stem Cell Trial to Treat Heart Disease
|
|
24 Mar 2007 |
Genta Announces Expectation of a Negative Opinion from the CHMP on Genasense(R) Application for Advanced Melanoma
|
|
23 Mar 2007 |
Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
|
|
21 Mar 2007 |
La Jolla Pharmaceutical Company (LJPC) Provides Update on Interim Antibody Results From Riquent(R) Lupus Phase 3 Trial
|
|
20 Mar 2007 |
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
|
|
15 Mar 2007 |
Transgene: First Patients Included in TG 1042 (Ad-IFNg) Phase II Clinical Trial in Cutaneous B-Cell Lymphoma
|
|
14 Mar 2007 |
Enzo Therapeutics Treats First Patient in Phase I/II Study of Antisense Gene Therapy for HIV-1 Infections
|
